bisbenzimidazole has been researched along with Infarction, Middle Cerebral Artery in 2 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, Z | 1 |
Bian, X | 1 |
Liu, X | 1 |
Zhu, Y | 1 |
Zhang, X | 1 |
Chen, S | 1 |
Wang, K | 1 |
Wang, Y | 1 |
Unal Cevik, I | 1 |
Dalkara, T | 1 |
2 other studies available for bisbenzimidazole and Infarction, Middle Cerebral Artery
Article | Year |
---|---|
Honokiol protects brain against ischemia-reperfusion injury in rats through disrupting PSD95-nNOS interaction.
Topics: Animals; Biphenyl Compounds; Bisbenzimidazole; Blotting, Western; Cell Hypoxia; Cells, Cultured; Cen | 2013 |
Intravenously administered propidium iodide labels necrotic cells in the intact mouse brain after injury.
Topics: Animals; Apoptosis; Biomarkers; Bisbenzimidazole; Brain; Brain Injuries; Cell Death; Hypoxia-Ischemi | 2003 |